HIV-1 nef protein structures associated with brain infection and dementia pathogenesis

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Lamers, Susanna L ^a,b   Poon, Art F Y ^c   McGrath, Michael S ^d,e  

^a POLYTECHNIC UNIVERSITY   (United States)

^b BIOINFOEXPERTS LLC   (United States)

^c British Columbia Centre for HIV/AIDs Excellence   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e AIDS and Cancer Specimen Resource   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; UGANDA; UNINDEXED SEQUENCE; VIRUS STRAIN; ANTIBODY SPECIFICITY; BRAIN; CHEMICAL STRUCTURE; CHEMISTRY; CONSENSUS SEQUENCE; DEMENTIA; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PHYLOGENY; POINT MUTATION; PROTEIN TERTIARY STRUCTURE; STRUCTURE ACTIVITY RELATION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AMINO ACID SEQUENCE; BRAIN; CONSENSUS SEQUENCE; DEMENTIA; HIV INFECTIONS; HIV-1; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; ORGAN SPECIFICITY; PHYLOGENY; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79951801671     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016659     Document Type: Article

References (56)

1. Williams KC, Hickey WF, (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annual Review of Neuroscience 25: 537-562.
2. Williams KC, Hickey WF, (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 25: 537-562.
3. Lamers SL, Salemi M, Galligan DC, Morris A, Gray R, et al. (2010) Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. Journal of Neurovirology 16: 230-241.
4. Zhao L, Galligan DC, Lamers SL, Yu S, Shagrun L, et al. (2009) High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS. Science in China Series C (Life Sciences) 52: 651-656.
5. Fischer-Smith T, Bell C, Croul S, Lewis M, Rappaport J, (2008) Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. Journal of Neurovirology 14: 318-326.
6. Fischer-Smith T, Rappaport J, (2005) Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Reviews in Molecular Medicine 7: 1-26.
7. Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K, et al. (2009) HIV subtype D is associated with dementia compared to subtype A in immunosuppressed individuals at risk for congnitive impairment in Kampala, Uganda. Clinical Infectious Diseases 72: 165-170.
8. Liner KJ, Hall CD, Robertson KR, (2007) Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. Journal of Neurovirology 13: 291-304.
9. Agopian K, Wei BL, Garcia JV, Gabuzda D, (2007) CD4 and MHC-I downregulation are conserved in primary HIV-1 nef alleles from brain and lymphoid tissues, but Pak3 activation is highly variable. Virology 358: 119-135.
10. Bergonzini V, Calistri A, Salata C, Del Vecchio C, Sartori E, et al. (2009) Nef and cell signaling transduction: a possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia. Journal of Neurovirology pp. 1-11.
11. Dunfee RL, Thomas ER, Wang J, Kunstman K, Wolinsky SM, et al. (2007) Loss of the N-linked glycosylation site at position 386 in the HIV envelope V4 region enhances macrophage tropism and is associated with dementia. Virology 367: 222-234.
12. Kim HJ, Martemyanov KA, Thayer SA, (2008) Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death. Journal of Neuroscience 26: 12604-12613.
13. Thomas ER, Dunfee RL, Stanton J, Bogdan D, Kunstman K, et al. (2007) High frequency of defective vpu compared with tat and rev genes in brain from patients with HIV type 1-associated dementia. AIDS Research and Human Retroviruses 23: 575-580.
14. van de Bovenkamp M, Nottet HS, Pereira CF, (2002) Interactions of human immunodeficiency virus-1 proteins with neurons: possible role in the development of human immunodeficiency virus-1 associated dementia. European Journal of Clinical Investigation 32: 619-627.
15. Carl S, Greenough TC, Krumbiegel M, Greenberg M, Skowronski J, et al. (2001) Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J Virol 75: 3657-3665.
16. Henao-Mejia J, Liu Y, Park IW, Zhang J, Sanford J, et al. (2009) Suppression of HIV-1 Nef translation by Sam68 mutant-induced stress granules and nef mRNA sequestration. Mol Cell 33: 87-96.
17. Schindler M, Munch J, Kutsch O, Li H, Santiago ML, et al. (2006) Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125: 1055-1067.
18. Foster JL, Garcia JV, (2006) HIV pathogenesis: Nef loses control. Cell 125: 1034-1035.
19. Klotman ME, Kim S, Buchbinder A, DeRossi A, Baltimore D, et al. (1991) Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci U S A 88: 5011-5015.
20. Choi HJ, Smithgall TE, (2004) Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase. J Mol Biol 343: 1255-1268.
21. Lehmann MH, Walter S, Ylisastigui L, Striebel F, Ovod V, et al. (2006) Extracellular HIV-1 Nef increases migration of monocytes. Exp Cell Res 312: 3659-3668.
22. Chaudhry A, Verghese DA, Das SR, Jameel S, George A, et al. (2009) HIV-1 Nef promotes endocytosis of cell surface MHC class II molecules via a constitutive pathway. J Immunol 183: 2415-2424.
23. Peterlin BM, Trono D, (2003) Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol 3: 97-107.
24. Speth C, Schabetsberger T, Mohsenipour I, Stockl G, Wurzner R, et al. (2002) Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J Virol 76: 3179-3188.
25. Trillo-Pazos G, McFarlane-Abdulla E, Campbell IC, Pilkington GJ, Everall IP, (2000) Recombinant nef HIV-IIIB protein is toxic to human neurons in culture. Brain Res 864: 315-326.
26. Garry RF, Kort JJ, Koch-Nolte F, Koch G, (1991) Similarities of viral proteins to toxins that interact with monovalent cation channels. AIDS 5: 1381-1384.
27. Werner T, Ferroni S, Saermark T, Brack-Werner R, Banati RB, et al. (1991) HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. AIDS 5: 1301-1308.
28. Kramer-Hammerle S, Hahn A, Brack-Werner R, Werner T, (2005) Elucidating effects of long-term expression of HIV-1 Nef on astrocytes by microarray, promoter, and literature analyses. Gene 358: 31-38.
29. Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, et al. (1995) Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9: 1001-1008.
30. Thompson KA, Kent SJ, Gahan ME, Purcell DF, McLean CA, et al. (2003) Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virus. J Neurovirol 9: 442-451.
31. Olivieri KC, Agopian KA, Mukerji J, Gabuzda D, (2010) Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes. AIDS Res Hum Retroviruses 26: 495-500.
32. Lamers SL, Salemi M, Galligan DC, De Oliveira T, Fogel GB, et al. (2009a) Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology. PLoS ONE 4: e5065.
33. Topham CM, Srinivasan N, Blundell TL, (1997) Prediction of protein mutants based on structural environment-dependent amino acid substitution and propensity tables. Protein Engineering 10: 7-21.
34. Worth CL, Bickerton GRJ, Schreyer A, Forman JR, Cheng TMK, et al. (2007) A structural bioinformatics approach to the analysis of non-synonymous single nucleotide polymorphisms and their relation to disease. Journal of Bioinformatics and Computational Biology special issue: Making Sense of Mutations Requires Knowledge Management 5.
35. Lim WA, (1996) Reading between the lines: SH3 recognition of an intact protein. Structure 4: 657-659.
36. van Marle G, Henry S, Todoruk T, Sullivan A, Silva C, et al. (2004) Human immunodeficiency virus type 1 nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 329: 302-318.
37. Masliah E, Ge N, Mucke L, (1996) Pathogenesis of HIV-1 associated neurodegeneration. Critical Reviews in Neurobiology 10: 57-67.
38. Gerlach H, Laumann V, Martens S, Becker CF, Goody RS, et al. (2010) HIV-1 Nef membrane association depends on charge, curvature, composition and sequence. Nature Chemical Biology 6: 46-53.
39. Geyer M, Fackler OT, Peterlin BM, (2001) Structure-function relationships in HIV-1 Nef. EMBO Reports 2: 580-585.
40. Herbein G, Gras G, Khan KA, Abbas W, (2010) Macrophage signaling in HIV-1 infection. Retrovirology 7: 34.
41. Costa LJ, Chen N, Lopes A, Aguiar RS, Tanuri A, et al. (2006) Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1. Retrovirology 9: 33.
42. Trible RP, Emert-Sedlak L, Smithgall TE, (2006) HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction. J Biol Chem 281: 27029-27038.
43. Ye H, Choi HJ, Poe J, Smithgall TE, (2004) Oligomerization is required for HIV-1 Nef-induced activation of the Src family protein-tyrosine kinase, Hck. Biochemistry 43: 15775-15784.
44. Choi HJ, Smithgall TE, (2004) Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase. Journal of Molecular Biology 343: 1255-1268.
45. Zheng J, Thylin MR, Ghorpade A, Xiong H, Persidsky Y, et al. (1999) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. Journal of Neuroimmunology 98: 185-200.
46. Greenberg ME, Iafrate AJ, Skowronski J, (1998) The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J 17: 2777-2789.
47. Mangasarian A, Piguet V, Wang JK, Chen YL, Trono D, (1999) Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J Virol 73: 1964-1973.
48. Saksela K, Cheng G, Baltimore D, (1995) Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 14: 484-491.
49. Dai L, Stevenson M, (2010) A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophages. J Virol 84: 8327-8331.
50. Banisadr G, Rostene W, Kitabgi P, Parsadaniantz SM, (2005) Chemokines and brain functions. Curr Drug Targets Inflamm Allergy 4: 387-399.
51. Irish BP, Khan ZK, Jain P, Nonnemacher MR, Pirrone V, et al. (2009) Molecular mechanisms of neurodegenerative diseases induced by human retroviruses: a review. American Journal of Infectious Disease 5: 231-258.
52. Lenassi M, Cagney G, Liao M, Vaupotic T, Bartholomeeusen K, et al. (2010) HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 11: 110-122.
53. Johannes L, Pezo V, Mallard F, Tenza D, Wiltz A, et al. (2003) Effects of HIV-1 Nef on retrograde transport from the plasma membrane to the endoplasmic reticulum. Traffic 4: 323-332.
54. Lindwasser OW, Smith WJ, Chaudhuri R, Yang P, Hurley JH, et al. (2008) A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2. J Virol 82: 1166-1174.
55. Marusic C, Vitale A, Pedrazzini E, Donini M, Frigerio L, et al. (2009) Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study. Transgenic Research 18: 499-512.
56. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, et al. (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19: 1367-1374.